
Artificial intelligence approaches for anti-addiction drug discovery.
AI revolutionizes anti-addiction drug discovery, enhancing efficacy and speed in targeting complex neurochemical systems. ππ
Discover the newest research about AI innovations in π§ͺ Drug Discovery.
AI revolutionizes anti-addiction drug discovery, enhancing efficacy and speed in targeting complex neurochemical systems. ππ
Amphetamine may lower Parkinson’s disease risk by 41% over 6 years, according to recent AI-driven research. π§ π
Machine learning reveals 11 hub biomarkers for coronary artery disease, highlighting ITM2B’s potential role in inflammation. π«π¬
Datavant acquires Aetion to enhance real-world evidence capabilities in healthcare. This merger aims to improve data sharing and analytics. ππ€
Deep learning enhances sonosensitizer-drug co-assembly, achieving 90% precision and 96% recall for cancer therapy. π‘π¬
Klebsiella pneumoniae’s rising virulence and antibiotic resistance pose significant health risks. π¦ π Explore novel therapeutic strategies!
South Korea’s government supports medtech firms with a new tariff center to address trade challenges. π°π·π
New AI method improves insights into cellular responses to drug treatments. π§¬π Researchers aim to enhance medical research and therapies.
Healthcare AI adoption is rising, with 70% of providers implementing technologies. However, data integration issues remain a challenge. ππ€
BioStruct-Africa’s workshops enhance structural biology skills in Africa, utilizing AI tools like AlphaFold for disease research. ππ¬